PlaqueTec and the Babraham Institute collaborate on early phase target discovery and development

FHS
May 14, 2024
9:59 am

Campus Innovation Award (CIA)-funded project evaluated lead compounds predicted to bind a pro-inflammatory protein discovered by PlaqueTec

A call to add sexual orientation and gender identity data to electronic health records

There are more openly LGBTQ+ people in the U.S. than ever, but little is known about the unique health challenges they may face. That’s why

January 26, 2024

U.K. researchers warn about biases in medical devices, health care algorithms

LONDON — Regulators, clinicians, and health care algorithm developers need to take additional steps to ensure that medical devices work equally well for all patients,

March 11, 2024

CMN-005 by CoImmune for Primary Mediastinal B-Cell Lymphoma: Likelihood of Approval

CMN-005 is under clinical development by CoImmune and currently in Phase II for Primary Mediastinal B-Cell Lymphoma.

September 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.